You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR SUBLOCADE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for SUBLOCADE

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT03604159 ↗	XRB vs. SLB in Jail and at Re-entry: Pilot, Proof of Concept	Completed	NYC Health + Hospitals	Phase 4	2019-06-24	This is a pilot proof-of-concept randomized controlled trial, open-label and unblinded, examining the feasibility and acceptability of Buprenorphine extended-release vs. daily sublingual buprenorphine-naloxone for the treatment of opioid use disorder in jail and at community re-entry.
NCT03604159 ↗	XRB vs. SLB in Jail and at Re-entry: Pilot, Proof of Concept	Completed	New York University School of Medicine	Phase 4	2019-06-24	This is a pilot proof-of-concept randomized controlled trial, open-label and unblinded, examining the feasibility and acceptability of Buprenorphine extended-release vs. daily sublingual buprenorphine-naloxone for the treatment of opioid use disorder in jail and at community re-entry.
NCT03604159 ↗	XRB vs. SLB in Jail and at Re-entry: Pilot, Proof of Concept	Completed	NYU Langone Health	Phase 4	2019-06-24	This is a pilot proof-of-concept randomized controlled trial, open-label and unblinded, examining the feasibility and acceptability of Buprenorphine extended-release vs. daily sublingual buprenorphine-naloxone for the treatment of opioid use disorder in jail and at community re-entry.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for SUBLOCADE

Condition Name

Chart
Table

Condition Name for SUBLOCADE
Intervention	Trials
Opioid Use Disorder	5
Opioid-use Disorder	4
Opioid Dependence	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for SUBLOCADE
Intervention	Trials
Opioid-Related Disorders	14
Substance-Related Disorders	4
Disease	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for SUBLOCADE

Trials by Country

Map
Table

Trials by Country for SUBLOCADE
Location	Trials
United States	11
Australia	4
Canada	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for SUBLOCADE
Location	Trials
New York	4
New Jersey	3
Virginia	2
Maryland	1
North Carolina	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for SUBLOCADE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for SUBLOCADE
Clinical Trial Phase	Trials
Phase 4	8
Phase 3	3
Phase 2	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for SUBLOCADE
Clinical Trial Phase	Trials
Not yet recruiting	5
Completed	4
Recruiting	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for SUBLOCADE

Sponsor Name

Chart
Table

Sponsor Name for SUBLOCADE
Sponsor	Trials
Indivior Inc.	6
National Institute on Drug Abuse (NIDA)	3
New York State Psychiatric Institute	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for SUBLOCADE
Sponsor	Trials
Other	14
Industry	6
NIH	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.